SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Doucet Terrence Gregory Joseph

(Last) (First) (Middle)
111 PETER STREET, SUITE 300

(Street)
TORONTO A6 M5V 2H1

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/20/2022
3. Issuer Name and Ticker or Trading Symbol
Cronos Group Inc. [ CRON ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON SHARES 1,599 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
COMMON SHARE OPTION (right to buy) (1) 05/17/2023 COMMON SHARES 60,000 7.57(2) D
COMMON SHARE OPTION (right to buy) (3) 03/28/2024 COMMON SHARES 4,198 24.75(2) D
RESTRICTED STOCK UNITS (4) (4) COMMON SHARES 21,643 0.0(5) D
Explanation of Responses:
1. The options were granted May 17, 2018 and vest in monthly installments over a four-year period.
2. The exercise price is expressed in Canadian dollars.
3. The options were granted March 28, 2019 and vest in quarterly installments over a four-year period.
4. The restricted share units ("RSUs") consist of the following: (1) 5,313 unvested RSUs vesting in substantially equal annual installments, with the second of three scheduled vesting dates to occur on December 17, 2022, (2) 4,679 unvested RSUs vesting in three substantially equal annual installments beginning on May 10, 2022, and (3) 11,651 unvested RSUs vesting in three substantially equal annual installments beginning on March 8, 2023, in each case, subject to continued employment through each applicable date.
5. Each RSU represents a contingent right to receive one common share of Cronos Group Inc.
Remarks:
Senior Vice President, Legal, Regulatory Affairs and Corporate Secretary. Exhibit List: Exhibit 24 - Power of Attorney.
Aaron Werner, as attorney-in-fact for Terry Doucet 04/28/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
doucetcronossection16aut
Terrence Gregory Joseph Doucet – Exhibit 24 Authorization and Designation to Sign and File Section 16 Reporting Forms The undersigned does hereby authorize and designate Aaron Werner, with right to substitute and resubstitute, but for only so long as he is an employee of Cronos Group Inc., a corporation incorporated under the Business Corporations Act (British Columbia) (the “Company”), to sign and file on his behalf the application for the required Securities and Exchange Commission (the “SEC”) electronic CIK/CCC codes and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the Company with the SEC pursuant to the requirements of Section 16 of the Securities Exchange Act of 1934, as amended (“Section 16”) and Rule 144 under the Securities Act of 1933, as amended. This authorization, unless earlier revoked in writing, shall be valid until the undersigned’s reporting obligations under Section 16 and Rule 144 with respect to equity securities of the Company shall cease. All prior such authorizations are hereby revoked. IN WITNESS WHEREOF, the undersigned has executed this Authorization and Designation this 20th day of April, 2022. Terrence Gregory Joseph Doucet